PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Standard

PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE. / Deschaine, Sara L.; Hedegaard, Morten A.; Sulima, Agnieszka; Moose, Jacob; Stock, Ingrid A.; Hougland, James L.; Akhlaghi, Fatemeh; Rice, Kenner C.; Holst, Birgitte; Leggio, Lorenzo.

In: Alcoholism: Clinical and Experimental Research, Vol. 45, No. Supl. 1/SI, 674, 2021, p. 146A-146A.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

Deschaine, SL, Hedegaard, MA, Sulima, A, Moose, J, Stock, IA, Hougland, JL, Akhlaghi, F, Rice, KC, Holst, B & Leggio, L 2021, 'PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE', Alcoholism: Clinical and Experimental Research, vol. 45, no. Supl. 1/SI, 674, pp. 146A-146A.

APA

Deschaine, S. L., Hedegaard, M. A., Sulima, A., Moose, J., Stock, I. A., Hougland, J. L., Akhlaghi, F., Rice, K. C., Holst, B., & Leggio, L. (2021). PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE. Alcoholism: Clinical and Experimental Research, 45(Supl. 1/SI), 146A-146A. [674].

Vancouver

Deschaine SL, Hedegaard MA, Sulima A, Moose J, Stock IA, Hougland JL et al. PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE. Alcoholism: Clinical and Experimental Research. 2021;45(Supl. 1/SI):146A-146A. 674.

Author

Deschaine, Sara L. ; Hedegaard, Morten A. ; Sulima, Agnieszka ; Moose, Jacob ; Stock, Ingrid A. ; Hougland, James L. ; Akhlaghi, Fatemeh ; Rice, Kenner C. ; Holst, Birgitte ; Leggio, Lorenzo. / PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE. In: Alcoholism: Clinical and Experimental Research. 2021 ; Vol. 45, No. Supl. 1/SI. pp. 146A-146A.

Bibtex

@article{c2c87e445650464f9ffd29a707689c57,
title = "PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE",
author = "Deschaine, {Sara L.} and Hedegaard, {Morten A.} and Agnieszka Sulima and Jacob Moose and Stock, {Ingrid A.} and Hougland, {James L.} and Fatemeh Akhlaghi and Rice, {Kenner C.} and Birgitte Holst and Lorenzo Leggio",
year = "2021",
language = "English",
volume = "45",
pages = "146A--146A",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "Supl. 1/SI",

}

RIS

TY - ABST

T1 - PHARMACOLOGICAL CHARACTERIZATION OF A GHRELIN RECEPTOR ANTAGONIST/ INVERSE AGONIST, PF-5190457, AND ITS MAJOR ACTIVE HYDROXY METABOLITE

AU - Deschaine, Sara L.

AU - Hedegaard, Morten A.

AU - Sulima, Agnieszka

AU - Moose, Jacob

AU - Stock, Ingrid A.

AU - Hougland, James L.

AU - Akhlaghi, Fatemeh

AU - Rice, Kenner C.

AU - Holst, Birgitte

AU - Leggio, Lorenzo

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

VL - 45

SP - 146A-146A

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - Supl. 1/SI

M1 - 674

ER -

ID: 274526091